Newer Drug Seems Better at Controlling Lupus Kidney Complication
Serious adverse events less likely with mycophenolate mofetil, too, study finds
Wednesday, November 16, 2011
A newer immune-suppressing drug called mycophenolate mofetil (CellCept) is better at controlling a serious kidney complication from lupus than another commonly used therapy, a new study suggests.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms